Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on Thursday, January 25, 2024.

The release will be accessible on Taro’s website at www.taro.com.

About Taro

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

William J. Coote VP, Chief Financial Officer (914) 345-9001 William.Coote@taro.com

Grafico Azioni Taro Pharmaceutical Indu... (NYSE:TARO)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Taro Pharmaceutical Indu...
Grafico Azioni Taro Pharmaceutical Indu... (NYSE:TARO)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Taro Pharmaceutical Indu...